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Background: Repeated exposure to addictive drugs elicits long-lasting cellular and molecular changes. It has been
reported that the aberrant expression of long non-coding RNAs (lncRNAs) is involved in cocaine and heroin addiction,
yet the expression profile of lncRNAs and their potential effects on methamphetamine (METH)-induced locomotor
sensitization are largely unknown.
Results: Using high-throughput strand-specific complementary DNA sequencing technology (ssRNA-seq), here we
examined the alterations in the lncRNAs expression profile in the nucleus accumbens (NAc) of METH-sensitized mice.
We found that the expression levels of 6246 known lncRNAs (6215 down-regulated, 31 up-regulated) and 8442 novel
lncRNA candidates (8408 down-regulated, 34 up-regulated) were significantly altered in the METH-sensitized mice.
Based on characterizations of the genomic contexts of the lncRNAs, we further showed that there were 5139
differentially expressed lncRNAs acted via cis mechanisms, including sense intronic (4295 down-regulated and
one up-regulated), overlapping (25 down-regulated and one up-regulated), natural antisense transcripts (NATs,
148 down-regulated and eight up-regulated), long intergenic non-coding RNAs (lincRNAs, 582 down-regulated
and five up-regulated), and bidirectional (72 down-regulated and two up-regulated). Moreover, using the program
RNAplex, we identified 3994 differentially expressed lncRNAs acted via trans mechanisms. Gene ontology (GO) and
KEGG pathway enrichment analyses revealed that the predicted cis- and trans- associated genes were significantly
enriched during neuronal development, neuronal plasticity, learning and memory, and reward and addiction.
Conclusions: Taken together, our results suggest that METH can elicit global changes in lncRNA expressions in
the NAc of sensitized mice that might be involved in METH-induced locomotor sensitization and addiction.
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It has been reported that repeated exposure to drugs of
abuse results in long-lasting behavioural changes such as
locomotor sensitization that are thought to be due to
structural and functional changes in associated brain
regions, particularly the NAc [1,2]. Previous studies have
indicated that addictive drugs induce persistent and* Correspondence: chenteng@mail.xjtu.edu.cn
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stated.dynamic cellular and molecular modifications accom-
panied by distinct processes of drug addiction [3-6]. The
complexity of drug-induced stable changes suggests that
synchronized programs of gene regulation might be exe-
cuted during drug addiction [7]; however, the precise
mechanism remains unclear.
Previous research has shown that addictive drugs in-
duce aberrant expression of non-coding RNAs (ncRNAs)
[8,9], the function of which are thought to be among the
most important mechanisms underlying gene regulation
[10,11]. For example, increasing evidence has demon-
strated that microRNAs play an important role in modu-
lating the potency of addictive drugs by mediating theis is an Open Access article distributed under the terms of the Creative Commons
/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
properly credited. The Creative Commons Public Domain Dedication waiver
zero/1.0/) applies to the data made available in this article, unless otherwise
Table 1 Statistical alignment of the sequencing data from
the saline and METH groups
Saline METH
Total clean reads 49621072 (100%) 50330816 (100%)
Total mapped reads 41689728 (84.02%) 40675732 (80.82%)
Perfect matcha 28650476 (57.74%) 27082591 (53.81%)
≤5 bp mismatchb 13039252 (26.28%) 13593141 (27.01%)
Unique matchc 36764592 (74.09%) 33138073 (65.84%)
Multi-position matchd 4925136 (9.93%) 7537659 (14.98%)
Total unmapped readse 7931344 (15.98%) 9655084 (19.18%)
aindicates clean reads that aligned without mismatch in the total mapped reads.
bindicates clean reads that aligned with fewer than 5 bp mismatches in the
total mapped reads.
crepresents the mapped reads that aligned to only one position in the
mouse genome.
drepresents the mapped reads that aligned to more than one positions in the
mouse genome.
eindicates reads that did not match to the mouse genome.
Table 2 Distribution of known lncRNAs detected by
ssRNA-seq
Saline METH
Known lncRNAsa 25677 (100%) 23579 (100%)
<5 RPKMb 18309 (71.31%) 18475 (78.35%)
5 ~ 100 RPKMc 6899 (26.87%) 4638 (19.67%)
≥100 RPKMd 469 (1.83%) 466 (1.98%)
arepresents lncRNA transcripts that were matched with NONCODE v3.0
bindicates the known lncRNAs that were expressed at a level below 5 RPKM.
cindicates the known lncRNAs that were expressed at a level between 5 and
100 RPKM.
dindicates the known lncRNAs that were expressed at a level greater than
100 RPKM.
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tential effects of lncRNA on drug addiction remain
largely unknown.
LncRNAs are defined as transcripts longer than 200 nt
that lack the ability to encode protein products [14]. As
transcriptional modulators and epigenetic regulators,
lncRNAs have been found to regulate the expressions
of proximal and distal protein-coding genes through
cis- and trans-acting mechanisms [11]. Emerging evi-
dence has implicated lncRNAs in neuroplasticity, brain
development, neurodegenerative, and neuropsychiatric
disorders [15-18], together, this evidence suggests a
meaningful role of lncRNAs in brain diseases including
drug addiction. Using microarrays, recent studies have
revealed that cocaine and heroin induce widespread alter-
ations of lncRNAs in the NAc of cocaine-conditioned
mice and heroin addicts [9,19],which suggests that
lncRNAs might play an important role in the regulation
of drug addiction. However, all of these studies targeted
small numbers of candidate lncRNAs and therefore
could not identify unknown lncRNAs and did not pro-
vide a complete spectrum of drug-induced changes in
lncRNA levels.
To investigate the expression profiles of lncRNAs and
their potential effects on METH-induced locomotor
sensitization in the current study, we examined the alter-
ations in lncRNAs expression profiles in the NAc of
METH-sensitized mice via the transcriptomics-based
approach, ssRNA-seq. We found that METH elicited
global changes in lncRNAs expression in the NAc of
mice and that predicted cis- and trans-associated genes
were significantly enriched during neuronal develop-
ment, neuronal plasticity, learning and memory, and
reward and addiction. Our results suggest that lncRNAs
might be involved in the regulation of expression of
associated genes and thus contribute to METH-induced
locomotor sensitization and addiction.
Results
SsRNA-seq summary
Complementary DNA samples generated from RNA that
was extracted from the NAc lysates of saline and
METH-treated mice were measured with ssRNA-seq. A
total of 49.62 million and 50.33 million clean reads were
obtained from the saline and METH groups of mice,
respectively. The clean reads of each group were then
separately aligned to the mouse genome (UCSC mm9)
[20] and 84.02% (saline) and 80.82% (METH) reads were
mapped to the reference genome, which included 28.65
million (saline) and 27.08 million (METH) perfectly
matched reads (Table 1). Additionally, among the total
mapped reads, there were 36.76 million (74.09%) and
33.14 million (65.84%) uniquely matched reads that were
obtained from the saline and METH groups of mice,respectively (Table 1). All of the mapped reads were then
assembled and annotated. Consequently, 25677 and 23579
lncRNAs were obtained from the saline and METH
groups of mice, respectively, by alignment to the database
of non-coding RNAs (NONCODE v3.0) [21] (Table 2).
The analysis of the relative expression levels (RPKM) of
these known lncRNAs revealed that the vast majority of
the lncRNAs (71.31% and 78.35% of the total known
lncRNA transcripts in saline and METH groups of mice
respectively) were expressed at the level of RPKM< 5
(Table 2). Moreover, we also identified 17860 and 15965
novel lncRNA candidates in the saline and METH groups,
that could not matched to any sequences that correspond
to known lncRNAs or protein-coding transcripts.
METH- induced aberrant expressions of lncRNAs in the NAc
of mice
To further identify the differentially expressed lncRNAs
in the NAc of the METH-sensitized mice, the RPKM
ratios of the lncRNAs in each group were subjected to
a log-2 transform to produce fold changes and thresh-
old based on a combination of statistical significance
(P < 0.001, FDR ≤ 0.0001) and the absolute value of the
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known lncRNAs exhibited significantly altered expres-
sions in the NAc of the METH-sensitized mice that in-
cluded 31 up-regulations and 6215 down-regulations
(Additional file 1). A volcano plot illustrated the vari-
ance in the lncRNAs numbers at different P-values and
fold changes (Figure 1).
Additionally, analysis of the novel lncRNA candidates
revealed that 8442 novel lncRNA candidates exhibited
significantly different expressions (P < 0.001, FDR ≤ 0.0001
and absolute value of the fold change ≥ 1.25) that included
34 increases and 8408 decreases (data were not shown).
Validation of lncRNAs expression by quantitative
real-time PCR
To validate the METH-induced changes in lncRNA ex-
pression that were detected by ssRNA-seq, 12 differen-
tially expressed lncRNAs were randomly selected, and
their expressions were then examined with quantitative
real-time PCR (qPCR). As shown in Figure 2, 10 of the se-
lected lncRNAs were significantly changed (eight down-
regulated and two up-regulated) in METH-sensitized mice
as detected by both ssRNA-seq (Figure 2A, #P < 0.001,
FDR ≤ 0.0001 and an absolute value of the fold change ≥
1.25 compared to the saline group of mice) and qPCR
(Figure 2B, *P < 0.05 compared to the saline group of
mice, n = 11-15 per group). Although the expression of
AK036791 and AK080587 detected by qPCR were not
significantly regulated, they showed similar expression
trends in qPCR and ssRNA-seq. Moreover, a strong
agreement across the two methods was observed in that
the results of the qPCR were similar to those obtained from
the ssRNA-seq analyses (Figure 2C, r= 0.89, P < 0.05).Figure 1 METH-induced global changes in lncRNA expressions
in the NAc of sensitized mice. Volcano plots providing P values and
fold change of known lncRNAs. Red point: the differentially expressed
lncRNAs at the level of P < 0.001, FDR≤ 0.0001 and an absolute value
of the fold change≥ 1.25.These data indicated the good reproducibility of the
observed expression changes in the lncRNAs based on
an independent method.
Genomic characterization of differentially expressed
known lncRNAs
To predict the potential role of lncRNAs in the regula-
tion of the expressions of protein-coding genes, we next
investigated the genomic context of the differentially
expressed known lncRNAs. LncRNAs can be classified
into intergenic lncRNAs, sense-overlap lncRNAs and
antisense-overlap lncRNAs based on their locations rela-
tive to protein-coding genes. Here, we identified 5141
sense-overlap (5128 down-regulated and 13 up-regulated),
172 antisense-overlap (164 down-regulated and eight
up-regulated) and 933 intergenic (923 down-regulated
and 10 up-regulated) lncRNAs among the differentially
expressed known lncRNAs that we detected (Figure 3).
LncRNAs in cis regulation
LncRNAs can regulate the expressions of genes that are
located on that same chromosome, and such regulation
is called cis regulation [11]. Based on their genomic
localization relative to nearby protein-coding genes,
lncRNAs can be further classified as sense intronic,
overlapping, NAT, lincRNA and bidirectional, and these
classes of lncRNAs have been reported to regulate their
protein-coding host genes in cis manners [22,23]. In the
present study, we subjected the differentially expressed
known lncRNAs to cis analysis, and we found that 82%
(5139 of 6246) of the differentially expressed known
lncRNAs could act in a cis manner, including 4296 sense
intronic lncRNAs, 26 overlapping lncRNAs, 156 NATs,
587 lincRNAs and 74 bidirectional lncRNAs (Figure 4A).
Sense intronic lncRNAs
Sense intronic lncRNAs originate from long introns that
are transcribed from the same strand as the associated
protein-coding genes. The sense intronic lncRNAs are
biologically significant because they have been found to
be both co-expressed with their host protein-coding gene
and independently expressed, particularly in the mouse
brain [24]. In the present study, we identified 4296 known
lncRNAs that were located in the introns of protein-
coding genes that include 4295 down-regulated and one
up-regulated lncRNAs (Figure 4A, Additional file 2).
Overlapping lncRNAs
Overlapping lncRNAs are lncRNAs contain a protein-
coding gene and are transcribed in the same direction as
that gene. This type of lncRNA can regulate downstream
transcription by opening the chromatin structure, de-
positing histone marks [25], and cis-acting promoter
competition [26]. Here, we identified 26 significantly
Figure 2 QPCR confirmations of the differential expressions of selected lncRNAs in METH-sensitized mice. A, Differentially expressed
lncRNAs as detected by ssRNA-seq. 12 significantly altered lncRNAs are shown with the corresponding RPKM. # indicates the following significance
cutoff: P < 0.001, FDR≤ 0.0001 and an absolute fold change value ≥1.25. B, Validation of differentially expressed lncRNAs by qPCR. The expressions of
the 12 selected lncRNAs were detected by qPCR. The expression levels were calculated relative to GAPDH. The values are presented as the means ±
the SEMs. The differences between the saline and METH groups were statistically tested with independent-sample t-tests. *P < 0.05 compared to saline,
n = 11-15. C, The ssRNA-seq and qPCR correlations are shown above. Pairwise scatterplots comparing the fold changes (log2 METH/saline) of the
selected lncRNAs in the NAc as computed from the ssRNA-seq data (horizontal axis) and the qPCR data (vertical axis). The Pearson’s Coefficient
is represented as the linear correlation coefficient, r.
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Figure 3 Genomic characterizations of the differentially
expressed lncRNAs. Sense-overlap: lncRNAs that overlapped with
the protein-coding genes that were transcribed from the same strand.
Antisense-overlap: lncRNAs that overlapped with the protein-coding
genes that were transcribed in the opposite direction. Intergenic
lncRNAs: lncRNAs with transcriptional units that were separate from
protein-coding genes. The numbers of each type of lncRNAs are
shown (y-axis).
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genes, including 25 decreased and one increased
lncRNAs (Figure 4A, Additional file 3).
NATs
NATs are lncRNAs that are transcribed from the anti-
sense strand of a gene locus, and are overlapping with the
RNA that transcribed from the sense strand. LncRNAs ofFigure 4 Cis and trans analyses of the differentially expressed lncRNA
Cis-acting lncRNAs are classified into sense intronic, overlapping, NAT, lincRNA
lncRNAs are shown (y-axis). B, Trans analyses of the differentially expressed kn
interactions with associated genes in one-to-one (a single lncRNA had one
associated genes) manners (x-axis). The numbers of each type of trans-acting lnthis type have been discovered to be widespread in the
mammalian genome and work through multiple mecha-
nisms to regulate the expressions of their sense partners
[27,28]. In the present study, we identified 156 differen-
tially expressed NATs that included 148 that were down-
regulated and eight that were up-regulated (Figure 4A,
Additional file 4). For example, the potassium voltage-
gated channel, subfamily Q, member 1, opposite strand/
antisense transcript 1 (Kcnq1ot1) [Genebank: NR_001461],
and the zinc finger homeobox 2, antisense (Zfhx2as)
[Genebank: AK032589] were found to be significantly
down-expressed in the METH-treated mice and have
previously been found to modulate the expression of
their sense partners [29,30].
LincRNAs
LincRNAs are found more than 10 kb away from any
nearby protein-coding locus [31,32]. A possible work-
ing model of the role of lincRNAs in gene regulation
involves their actions as enhancers that activate tran-
scriptional promotion and chromatin looping [33,34].
We identified 587 lincRNAs that were significantly al-
tered in the METH-sensitized mice, including 582 that
were down-regulated and five that were up-regulated
(Figure 4A, Additional file 5). Several lincRNAs, in-
cluding nuclear-enriched abundant transcript 2 (Neat2)s. A, Cis analyses of the differentially expressed known lncRNAs.
and bidirectional (x-axis) and the numbers of each type of cis-acting
own lncRNAs. The differentially expressed lncRNAs could exhibit trans
associated gene) or one-to-more (a single lncRNA had more than one
cRNAs are shown (y-axis). C, Overlap of the cis- and trans-acting lncRNAs.
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transcript 1 (Neat1) [Genebank: GQ859163], and myocar-
dial infarction associated transcript (Miat) [Genebank:
NR_033657], that were significantly down-regulated by
METH have previously been characterized as possessing
neurological functions [15,16].
Bidirectional lncRNAs
Bidirectional lncRNAs are oriented head-to-head with a
protein-coding gene within 1 kb, but are transcribed in
the opposite direction. Bidirectional lncRNAs have been
shown to affect the cis regulation of the nearby protein-
coding genes potentially via promoter competition or
the maintenance of an open chromatin structure [35,36].
We identified 74 aberrantly altered lncRNAs that formed
bidirectional pairs with protein-coding genes in the
current study (Figure 4A, Additional file 6) that included
72 down-regulated and two up-regulated lncRNAs.
LncRNAs in trans regulation
LncRNAs can work in a trans manner when they affect
genes on other chromosomes [11]. Previous studies have
shown that lncRNAs can interact with associated
mRNAs via the formation of complementary hybrids
[37,38]. Therefore, using the RNAplex program [39], we
subjected the differentially expressed known lncRNAs to
trans-analysis and found that 64% (3994 of 6246) of the
differentially expressed known lncRNAs were capable of
acting in a trans manner, and 2386 of the associated
genes have been found. We further investigated the
networks formed by the trans-acting lncRNAs and their
associated genes, which are termed the ‘many-to-many’
type; i.e., one lncRNA can have one or more associated
genes. As shown in Figure 4B, 403 down-regulated
lncRNAs exhibited one-to-one trans-regulation relation-
ships with protein-coding genes (Additional file 7). In
contrast, over 90% lncRNAs (3591 of 3994) might have
more than one trans-associated gene. Additionally, the
cis- and trans-acting lncRNAs also overlapped, and 3838
known lncRNAs were identified as having both cis- and
trans-associated genes (Figure 4C).
Functional analyses of the cis- and trans-associated genes
To further investigate the potential effects of known
lncRNAs on METH-induced locomotor sensitization, we
subjected the cis- and trans-associated genes to GO and
KEGG pathway analyses. Using P < 0.05 and FDR < 0.05
as cutoff for significance, we found that the predicted cis
and trans-associated genes were significantly enriched in
axon guidance, ubiquitin mediated proteolysis, neuron
projection, the MAPK signalling pathway, long-term
potentiation (LTP), long-term depression (LTD), calcium
signalling pathway, dopaminergic synapse, and gluta-
matergic synapse; these processes are generally linked toneuronal development, neuronal plasticity, learning and
memory, and reward and addiction (Figure 5, see full list
in Additional files 8 and 9).
Discussion
Previous studies have found that the expressions of
lncRNAs are aberrantly altered in the NAc of cocaine-
conditioned mice and heroin addicts, which suggests an
important role of lncRNAs in drug addiction [9,19].
Nevertheless, the expression profiles of lncRNAs and
their potential effects on METH-induced locomotor
sensitization are largely unknown. Here, we used high-
throughput ssRNA-seq technology to examine the alter-
ation in the lncRNAs expression profile in the NAc of
METH-sensitized mice. Using a stringent threshold for
statistical significance (P < 0.001, FDR ≤ 0.0001 and an
absolute value of the fold change ≥ 1.25), we identified
numerous (6246) METH-regulated lncRNAs (Additional
file 1), and 125 of these lncRNAs were also significantly
altered in the NAc of cocaine-conditioned mice [9].
Interestingly, the differentially expressed lncRNAs were
less likely to be up-regulated and more likely to be
down-regulated in the METH-sensitized mice. These
data are consistent with the pattern of lncRNA expres-
sion in the NAc of cocaine-treated mice [9]. Although
the precise regulatory mechanism remains unclear, these
results suggest that METH might reduce the expressions
of lncRNAs. Further studies are needed to investigate the
potential role of these differentially expressed lncRNAs.
Nevertheless, our findings suggest that lncRNAs might be
involved in METH addiction and provide new insight
into the molecular mechanisms of METH abuse. To our
knowledge, this is the first description of global lncRNAs
expression profiling in the context of METH-induced
behavioural sensitization. Moreover, our results provide
numerous of METH-responsive lncRNA candidates for
further functional research.
It has been shown that lncRNAs originate from complex
loci that contain interlaced networks of long non-coding
and protein-coding transcripts [40,41]. Analysis of the
genomic characterization of lncRNAs is helpful in predict-
ing their regulatory effects at the biological level. Indeed, a
number of previously characterized lncRNAs have been
proven to regulate the expressions of protein-coding genes
that share genomic loci with the lncRNAs [30,42,43]. In
the present study, we found that lncRNAs were associated
with protein-coding genes in a variety of manners that
included sense intronic, overlapping, lincRNA, NAT
and bidirectional. From the perspective of the lncRNAs
in their genomic context, our findings suggest the po-
tential functions of these lncRNAs in terms of METH
sensitization. Furthermore, lncRNAs have been re-
ported to be involved in regulation of gene expression
through trans-acting pathways in which they affect
Figure 5 GO and pathway analyses of the cis- and trans-associated genes. A, GO and pathway analyses of the cis-associated genes; B, GO
and pathway analyses of the trans-associated genes. The significantly enriched GO terms and pathways (P < 0.05 and FDR < 0.05) within certain
neurological functions ( 1–44) associated with neuronal development (1–11), neuronal plasticity (12–32), learning and memory (33-37), and reward and
addiction ( 38–44), are shown with the numbers of down-regulated lncRNAs, up-regulated lncRNAs, and the associated genes that were identified by
cis and trans analyses, respectively.
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numerous of METH-regulated lncRNAs interacted with
associated protein-coding genes in trans manners,
which suggests that these lncRNAs might be biologic-
ally meaningful. Notably, the trans-acting lncRNAs
were found to form a “many-to-many” network withtheir associated genes, which reflects the complexity of
the mechanisms of the regulation of METH-regulated
lncRNAs. Interestingly, five lncRNAs (Kcnq1ot1, Zfhx2as,
Neat1, Neat2, and Miat) that were found to be regulated
by METH in our study have been reported to interact in
cis or trans manners with targeted loci. For example, the
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regulate the expressions of their sense partners [29,30],
which have been reported to be involved in the modula-
tion of LTP in the hippocampus [44] and behavioural
abnormalities [45], respectively. It has been reported
that Neat1, Neat2 and Miat function as cofactors for
pre-mRNA splicing by interacting with the splicing fac-
tors [46-48], and significantly, Neat2 appears to regulate
neuronal plasticity by modulating the expressions of
multiple synaptic genes [15], which suggests that
lncRNAs-related nuclear modification might play a role
in METH addiction through rapid post-transcriptional
changes in gene expression. Notably, a preliminary
examination of a published dataset based on heroin
abusers revealed up-regulations of NEAT1, NEAT2 and
MIAT [19], which is suggestive of differential responses
across different drugs of abuse. Although the precise
regulatory mechanism remains unclear, these well-
characterized lncRNAs might play roles in terms of
METH abuse. Taken together, the identification of cis
and trans-acting lncRNAs suggests the potential func-
tional implications of METH-regulated lncRNAs that
might control the expressions of proximal or distal
associated genes and thus contribute to METH-induced
locomotor sensitization and addiction.
A major function of lncRNAs appears to be the control
of the gene expression via cis- and trans-acting pathways
[11]. Thus, functional analyses of cis- and trans-associated
genes are helpful for predicting the potential effects of
lncRNAs on METH-induced locomotor sensitization. In
the present study, we found that the predicted cis- and
trans-associated genes were significantly enriched during
neuronal development, neuronal plasticity, learning and
memory, and reward and addiction (Figure 5). Previous
studies have demonstrated that the neuronal plasticity that
occurrs as a consequence of exposure to drugs of abuse
plays a critical role in the modulation of persistent addict-
ive behaviours [49-51]. Similarly, it has been reported that
chronic exposure to drugs of abuse modulates learning
and memory, which are thought to underlie rewarding
and addictive behaviours [52-54]. Therefore, our findings
suggest that the lncRNAs that were modified by METH in
this study might influence the expressions of genes that
are involved in neuronal plasticity, learning and memory
and thus contribute to METH addiction.
Moreover, we unexpectedly found that sense intronic
lncRNAs comprised the largest portion of the cis-lncRNAs.
Previous studies have demonstrated that intronic lncRNAs
can either be transcriptional segments of processed mRNAs
or independent transcripts that are simply located within
intron-annotated genomic regions, and intronic lncRNAs
that originated from pre-mRNAs are thought to be the
main actors in the regulation of gene expression [55,56].
However, current evidence indicates that intronic lncRNAsthat exhibit independent transcription might also be
biologically significant [24,57-59]. Although the ssRNA-
seq technique used in this study cannot determine
whether these intronic lncRNAs are alternative splicing
products of a pre-mRNA or independent transcripts,
METH-regulated sense intronic lncRNAs were found to
originate from the intronic regions of the corresponding
protein-coding genes, such as calcium/calmodulin-
dependent protein kinase IV (Camk4), cAMP response
element-binding protein 1(Creb1), CREB-binding pro-
tein (Crebbp), glutamate receptor, ionotropic, AMPA1
(alpha 1) (Gria1) and mitogen-activated protein kinase
10(Mapk10), which have been suggested to be responsible
for synaptic transmission and specific signal transduction
in long-term drug-induced neuroadaptation. Further
experiments are needed to investigate the precise na-
tures of these sense intronic lncRNAs. These results
suggest that the sense intronic lncRNAs might play an
important role in the regulation of METH-induced
locomotor sensitization.
Conclusions
In summary, we reported a transcriptional profiling
of lncRNAs in the NAcs of METH-sensitized and
control mice. We have identified a number of METH-
responsive lncRNAs. The predicted cis- and trans-as-
sociated genes of these METH-regulated lncRNAs
were significantly enriched during the cellular and mo-
lecular events that contribute to reward and addiction.
Although further experiments are needed to investi-
gate the distinct function and the precise regulatory
mechanism of each candidate lncRNA, our data sug-
gest that exposure to METH elicits a global alterations
in lncRNA expression in the NAc of sensitized mice




Adult wild-type C57BL/6 mice (7–8 weeks old, male,
20-25 g), purchased from Beijing Vital River Laboratory
Animal Technolxogy Co. Ltd were used for these experi-
ments. The mice were kept maintained in a regulated en-
vironment (23 ± 1°C, 50 ± 5% humidity) on a 12-h light/
dark cycle (lights on from 7:00 am to 7:00 pm) and were
handled in accordance with the Institutional Animal Care
and Use Committee of Xi’an Jiaotong University. All
efforts were made to minimize the number of animals used
and to reduce stress from handling during the injections.
Drugs
The METH hydrochloride used for the tests was pur-
chased from the National Institute for the Control of
Pharmaceutical and Biological Products (Beijing, P.R.
Zhu et al. BMC Neuroscience  (2015) 16:18 Page 9 of 13China), and was dissolved in 0.9% physiological saline.
The volume of the intraperitoneal (i.p.) injections was
10 ml/kg.
Procedure of METH exposure
The treatment regimens used in the current study have
been shown to produce robust locomotor sensitization
in our previous studies [2,6]. Briefly, the mice were given
once-daily injections of saline for two consecutive days
(day 1–2), after which they were randomly divided into
two groups. The groups of mice were then given once-
daily injections of METH (2 mg/kg) or saline for five
consecutive days (day 3–7) followed by two injection-
free days (day 8–9). On day 10, the mice were given a
challenge injection of either 2 mg/kg METH or saline.
Horizontal locomotor activity was performed on all drug
treatment days for 60 minutes before and after the injec-
tions. The injections were performed in the open field
test apparatus and during the light phase of the light/
dark cycle. On the drug injection days, the mice were
brought into the behaviour room 60 min prior to the be-
ginning of the experiments to acclimate to the new en-
vironment. For all experiments, the mice were sacrificed
24 h after the final injection.
NAc sample preparation and RNA isolation
After the mice were sacrificed, the brains were micro-
dissected and the NAcs were harvested and immediately
frozen in liquid nitrogen. NAc lysates from eight mice
from each group were pooled for total RNA isolation,
following the instructions of the manufacturer of TRIzol
(Invitrogen, USA). One saline and one METH sample
were prepared from the RNAs that were extracted from
the pooled NAc lysates and these samples were referred to
as the saline and METH samples. The RNA qualities were
evaluated with an Agilent 2100 BioAnalyzer (Agilent
Technologies, USA), and all samples exhibited an RIN > 8.
Strand-specific cDNA library construction and sequencing
After the total RNA passed the RNA quality control for
deep sequencing, we prepared to construct the strand-
specific cDNA libraries. Briefly, the total RNA (5 μg)
from each sample was fragmented into ~200 base pair
(bp) units using a Covaris-S2 system after the removal of
the rRNA without preselecting the mRNA. Next, the
RNA fragments were used to generate double-stranded
cDNA. The first cDNA strand was synthesized using
random hexamers, and the second strand of cDNA was
synthesized using deoxy-UTP instead of deoxy-TTP with
DNA polymerase I. Then the double-stranded cDNAs
were end-repaired after purification with a QiaQuick
PCR kit, and the adapters were ligated. Subsequently,
the uridine-containing strand was destroyed by uracil-
N-glycosylase, which enabled the identification of thetranscript orientation. Subsequently, to acquire the se-
quencing library products, the single-stranded adapted
cDNA fragments of 200 bp were recovered and purified
with agarose gel electrophoresis and then enriched by
PCR for 12 cycles. The purified cDNA library products
were evaluated using the Agilent 2100 BioAnalyzer and
then sequenced on an Illumina HiSeq 2000.
SsRNA-seq data analyses
After sequencing, the raw reads that were generated by
sequencers, were saved in the fastq format. To obtain
reliable clean reads, the dirty raw reads were filtered
according to four criteria: reads with sequence adaptors
were removed; reads with more than 5% ‘N’ bases were
removed; low-quality reads, in which more than 50% of
the QA were ≤ 15 bases were removed; and ribosomal
RNA sequences that were obtained from the ribosomal
RNA database SILVA [60] by the software SOAP v2.2.0
[61] were removed based on an allowance of no more
than three mismatched bases. All subsequent analyses
were based on clean reads. The clean reads of the saline
and METH groups were separately aligned to the mouse
genome, UCSC mm9 [20] using the software TopHat
v2.0.4 [62]. Mismatches of no more than 5 bp were
allowed in the alignment of each read. The resulting
alignment data from TopHat were then assembled into
transcripts by the assembler Cufflinks v2.0.0 [63]. The as-
sembled transcripts that corresponded to known lncRNAs
were determined by perfect sequence matching to the
NONCODE v3.0 database of known non-coding RNA [21].
Furthermore, the assembled transcripts were aligned to
protein databases, including KEGG Orthology [64], non-re-
dundant protein database [65], COG [66] and UniProtKB/
Swiss-Prot [67], to obtain protein-coding transcripts. To
obtain novel non-coding transcript candidates, the re-
maining transcripts that were not matched to any known
lncRNAs or protein-coding sequences were then used to
predict their abilities to encode proteins using the Coding
Potential Calculator (CPC) [68], which based on framefin-
der. Thus, the transcripts that lacked the ability to encode
proteins were considered as novel lncRNA candidates.
The clean reads that were uniquely mapped to lncRNAs
were used to calculate the expression levels. The relative
expression levels of the lncRNAs in the saline and METH
groups were measured as the number of uniquely mapped
reads per kilobase per million mappable reads (RPKM).
The formula was defined as follows: RPKM= 106 × C/
(NL × 10−3), where C was the number of reads that
uniquely mapped to the given transcript, N was the num-
ber of reads that uniquely mapped to all transcripts, and L
was the total length of the given transcript. The RPKM
method eliminates the influences of different transcript
lengths and sequencing discrepancies on the calculation of
expression. Therefore, the RPKM value was directly used
Zhu et al. BMC Neuroscience  (2015) 16:18 Page 10 of 13to compare the differences in lncRNA expressions be-
tween samples. The fold change from the normalized ex-
pression was calculated as log2 (RPKMMETH/RPKMsaline)
to assess the levels. Because we only had one replicate
per group, the variances of regulated levels were directly
estimated from the RPKM values using the Poisson
distribution, and P-values were calculated [69]. There-
fore, to compensate for false-positive findings at each
significance threshold, we calculated a false discovery
rate (FDR; Benjamini-Hochberg) for each lncRNA and
applied it for genome-wide corrections [70]. We identi-
fied lncRNAs that were differentially regulated between
the METH and saline groups based on the following
criteria: P < 0.001, FDR ≤ 0.0001 and absolute value of
the fold change ≥ 1.25.
Cis and trans analyses
Identification of the genes associated with differentially
expressed lncRNAs via cis-or trans-regulation might pro-




























The primer pairs were chosen to maintain the melt temperature (Tm) between 45°Csubjected the significantly changed known lncRNAs to cis
and trans analyses. For the cis analyses, we classified the dif-
ferentially expressed lncRNAs into the following 5 categor-
ies according to their genomic contexts relative to protein-
coding genes: sense intronic, overlapping, NAT, lincRNA
and bidirectional. For the trans analyses, we predicted
the trans-associated genes of the differentially expressed
lncRNAs with RNAplex v0.2, which is a fast tool for RNA-
RNA interaction searches by neglecting intramolecular in-
teractions and by using as lightly simplified energy model
[39]. The RNAplex parameters were set as –e < −20 in the
current study to identify the trans-associated genes [9], and
genes that were found to be located on that same chromo-
some as the lncRNA were excluded.
GO and KEGG pathway enrichment analyses
For the GO and KEGG pathway enrichment analyses, the
cis- and trans-associated genes of the lncRNAs that were
significantly modified in the METH-sensitized mice were
analysed with the functional annotation tool Blast2GOdata
Tm(°C) Product length (bp)
-3′ 60 134
AT-3′ 58
T -3′ 62 132
CC -3′ 62






















and 62°C and the product lengths between 80 and 200 bp.
Zhu et al. BMC Neuroscience  (2015) 16:18 Page 11 of 13[71]. First, all associated genes were mapped to GO terms
and pathways in the gene ontology [72] and KEGG path-
way [73] databases by calculating the gene numbers for
every term and pathway. Then the P values were calcu-
lated via hypergeometric tests and go through a correction
with FDR. P < 0.05 and FDR < 0.05 were used as thresh-
olds for defining significantly enriched GO terms and
pathways. Finally, the associated genes that corresponded
to specific biological functions were filtered.
QPCR analyses
QPCR was performed on the RNAs isolated from the
NAcs of individual mice (n = 11-15 per group). First-strand
cDNA was synthesized using the Thermo Scientific Rever-
tAid First Strand cDNA Synthesis Kit (Thermo Scientific,
USA). Based on the manufacturer’s instructions and sug-
gested parameters (25°C 5 min, 42°C 60 min, and 70°C
5 min), 500 ng of total RNA from each sample was utilised.
QPCR was performed on Bio-Rad iQ™5 system real-time
detection instrument (Bio-Rad, USA) using SYBR Premix
Ex Taq II (TaKaRa Biotechnology, Japan) in the following
conditions: 95°C for 30 sec; 95°C for 10 sec and 60°C for
1 min, which were repeated for 40 cycles. GAPDH was
used as an endogenous control for the qPCR, and the rela-
tive expression levels were determined by the 2-△△Ct
method. Fold changes in expression were calculated with a
log 2 transform. Independent-sample t-tests were used to
test for significant differences (SPSS v17.0, SPSS Inc., USA).
The primer pairs are shown in Table 3. Pearson’s coefficient
analysis was also performed with SPSS (version 17.0, USA).
Availability of supporting data
The raw sequences have been deposited in the ArrayEx-
press database (www.ebi.ac.uk/arrayexpress) under acces-
sion number E-MTAB-2843.Additional files
Additional file 1: Full list of the METH-regulated lncRNAs.
Additional file 2: Full list of the sense intronic lncRNAs that were
significantly regulated by METH.
Additional file 3: Full list of the overlapping lncRNAs that were
significantly regulated by METH.
Additional file 4: Full list of the NATs that were significantly
regulated by METH.
Additional file 5: Full list of the lincRNAs that were significantly
regulated by METH.
Additional file 6: Full list of the bidirectional lncRNAs that were
significantly regulated by METH.
Additional file 7: Full list of the one-to-one trans-acting lncRNAs
that were significantly regulated by METH.
Additional file 8: Full list of the GO and pathways of the cis-acting
lncRNAs and their associated genes.
Additional file 9: Full list of the GO and pathways of the trans-acting
lncRNAs and their associated genes.Abbreviations
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